Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
50 participants
OBSERVATIONAL
2025-06-01
2027-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methoxyflurane for IUD Insertion and Endometrial Biopsy
NCT07046572
Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage
NCT03872700
Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children
NCT02653742
Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media
NCT02092454
Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults
NCT02410707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing an otolaryngology in-office procedure using methoxyflurane
All adult patients undergoing any of the following procedures with inhaled methoxyflurane as an adjunct to topical or local anesthesia:
* Skin lesion excision or reconstruction
* Fine or core needle aspiration biopsy
* Mucosal biopsy
* Laryngeal injection or biopsy
* Myringotomy with or without tympanostomy tube insertion
* Inferior turbinate reduction
* Septal button insertion
Methoxyflurane anesthesia
A single Penthrox (3mL) self-inhaler will be administered 5-minutes prior to the onset of the procedure, before local anesthesia. Patients will undergo the procedure, have post-procedural vital signs, and remain in clinic for observation for 30 minutes post-procedure per our usual post-procedure monitoring.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methoxyflurane anesthesia
A single Penthrox (3mL) self-inhaler will be administered 5-minutes prior to the onset of the procedure, before local anesthesia. Patients will undergo the procedure, have post-procedural vital signs, and remain in clinic for observation for 30 minutes post-procedure per our usual post-procedure monitoring.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Skin lesion excision or reconstruction
* Fine or core needle aspiration biopsy
* Mucosal biopsy
* Laryngeal injection or biopsy
* Myringotomy with or without tympanostomy tube insertion
* Inferior turbinate reduction
* Septal button insertion
Exclusion Criteria
* Presence of any contraindications to inhaled methoxyfluorane per product monograph:
* Patients less than 18 years of age
* Pregnancy, intended pregnancy, or current breast-feeding
* Inadequate patient understanding or lack of cooperation
* Decreased level of consciousness or head injury
* History of clinically significant renal impairment, e.g., reduced renal output
* History of liver dysfunction following previous exposure to halogenated anesthetics
* Current use of tetracycline antibiotics
* Personal or genetic history of malignant hyperthermia
* Muscular dystrophy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sir Mortimer B. Davis - Jewish General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-4462
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.